American Healthcare REIT (AHR) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD85,197.00+0.54%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

American Healthcare REIT Inc (AHR) Stock Price, Quote, News & History

AHRNYSE

Trade with Public

Trade with Public

$50.75

0.060.12%

Last update: Oct 2, 4:00 PM

$50.75

0.060.12%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$50.92

Close

$50.75

Volume / Avg.

2.44M / 2.96M

Day Range

$50.57 - $51.70

52 Wk Range

40.00 - 58.70

Market Cap

$11.06B

P/E Ratio

74.54

Dividend Yield

1.97%

Exchange

NYSE

RSI

31

Short Interest

12.96%

Days to Cover

9.27

Recent American Healthcare REIT, Inc. News

How AHR’s $873M Kensington Deal Could Shift Its Dividend Payout Ratio

The Print American Healthcare REIT, Inc. (NYSE:AHR) has closed six of the eight senior housing communities in its $873 million Kensington Senior Living portfolio. The first closings total approximately $572 million

Jeong-Mo Goo

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.

Avi Kapoor

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.

Avi Kapoor

This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Piper Sandler upgraded SNPS, JP Morgan upgraded IBM,. See analyst ratings.

Avi Kapoor

Top 3 Real Estate Stocks That Could Blast Off In March

Opportunity to buy undervalued real estate stocks with RSI near or below 30. Oversold companies include AHR, SITC, and O with recent stock decreases and low RSI values.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

362.04M

Investing Cash Flow (TTM)

-1.36B

Financing Cash Flow (TTM)

1.02B

Free Cash Flow (TTM)

195.55M

Capital Expenditure (TTM)

-166.49M

Net Change in Cash (TTM)

21.72M

Analyst Trends and Forecast

2

May

1

Jun

3

Jul

5

Aug

0

0

0

0

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.47B

PE Ratio (TTM)

74.54

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.70

PB Ratio (TTM)

2.99

Earnings Yield % (TTM)

1.34%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

27.31

Price / EBITDA (TTM)

20.28

Price / Free Cash Flow (TTM)

47.32

Book Value / Share

$16.95

Company Debt

Total Debt

$1.44B

LT Debt

$892.68M

LT Debt Issuance (TTM)

$116.00M

LT Debt Repayment (TTM)

-$231.32M

Total Cash

$156.90M

Debt to Equity

0.42

Issuance of Debt (TTM)

-$115.32M

Repayment of Debt (TTM)

-$231.32M